Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-052685
Filing Date
2025-04-10
Accepted
2025-04-10 08:39:55
Documents
1
Period of Report
2025-04-08

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3452
  Complete submission text file 0000950170-25-052685.txt   4864
Mailing Address 5791 VAN ALLEN WAY CARLSBAD CA 92008
Business Address
Pescovitz Ora H. (Reporting) CIK: 0001519624 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42272 | Film No.: 25826608

Mailing Address 11711 N. MERIDIAN STREET SUITE 300 CARMEL IN 46032
Business Address 11711 N. MERIDIAN STREET SUITE 300 CARMEL IN 46032 3179893100
MBX Biosciences, Inc. (Issuer) CIK: 0001776111 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)